Recombinant Hylobates lar NADH-ubiquinone oxidoreductase chain 4L (MT-ND4L)

Basic Research Questions

• What is the function of MT-ND4L in mitochondrial Complex I?

  MT-ND4L is an integral component of Complex I (NADH:ubiquinone oxidoreductase), which is responsible for the first step in the electron transport process during oxidative phosphorylation. Within the inner mitochondrial membrane, Complex I transfers electrons from NADH to ubiquinone, creating an electrical charge difference that drives ATP production. MT-ND4L specifically contributes to the membrane-embedded hydrophobic arm of Complex I and is involved in proton pumping mechanisms . The protein helps create the unequal electrical charge on either side of the inner mitochondrial membrane through the step-by-step transfer of electrons, which ultimately provides the energy for ATP synthesis .

• How is MT-ND4L encoded and transcribed?

  MT-ND4L is encoded by the mitochondrial genome (mtDNA), specifically by the MT-ND4L gene. Unlike nuclear genes, mitochondrial genes like MT-ND4L often have no or very short 5' untranslated regions (typically less than 4 nucleotides) . This creates leaderless mRNAs, where mitochondrial ribosomes must initiate translation directly at the start codon. The gene is transcribed as part of a polycistronic transcript and then processed to form the mature mRNA. According to genomic data, human MT-ND4L is located at positions 10470 to 10766 on the mitochondrial chromosome .

• What is the evolutionary conservation of MT-ND4L among primates?

  MT-ND4L shows significant evolutionary conservation, particularly at functional domains. Research indicates that certain amino acid positions in MT-ND4L, such as position 71, are highly conserved in eukaryotes (86%), mammals (97%), and completely invariant in primates . This conservation extends to a stretch of 16 amino acids that is invariant across primates, suggesting critical functional importance . Phylogenetic studies of gibbons and other hylobatids frequently include MT-ND4L sequences, indicating its utility in evolutionary analyses of primate species .

• What techniques are commonly used to analyze MT-ND4L in research settings?

  Several techniques are utilized for studying MT-ND4L:

  Technique	Application	Resolution
  Polymerase Chain Reaction (PCR)	Amplification of MT-ND4L sequences	Sequence-level analysis
  Blue-Native Gel Electrophoresis (BNGE)	Analysis of Complex I assembly	Protein complex level
  Complexome Profiling	Detailed analysis of protein complex assembly	Subunit association patterns
  Whole Exome Sequencing (WES)	Identification of variants in MT-ND4L	Nucleotide-level variants
  Mitoribosome Profiling	Translation dynamics of MT-ND4L	Ribosomal positioning

  For example, in mitoribosome profiling, researchers can identify translation initiation sites on mitochondrial transcripts by analyzing the distribution of mitoribosome footprints of different lengths .

Advanced Research Questions

• How do mutations in MT-ND4L contribute to mitochondrial disorders?

  Mutations in MT-ND4L have been associated with several disorders, particularly Leber hereditary optic neuropathy (LHON). One specific mutation, T10663C (or Val65Ala), has been identified in several LHON families . This mutation changes a single amino acid in the protein (valine to alanine at position 65). Additionally, the m.10680G>A variant in MT-ND4L has been reported as a pathogenic change in three LHON families with different mitochondrial haplogroup backgrounds (B4a1e, M13a1b, and D6a1) .

  Beyond LHON, research has identified an association between a rare MT-ND4L variant (rs28709356 C>T) and Alzheimer's disease risk (P = 7.3 × 10⁻⁵), with gene-based tests also showing significant association (P = 6.71 × 10⁻⁵) .

  These mutations likely disrupt Complex I function, affecting energy production and potentially increasing oxidative stress, though the precise mechanisms remain under investigation .

• What is the significance of combinatorial effects of mutations in MT-ND4L and other mitochondrial genes?

  Research has revealed that combinations of individually non-pathogenic variants in mitochondrial genes can collectively contribute to disease phenotypes. For example, the combination of m.10680G>A in MT-ND4L, m.12033A>G in MT-ND4, and m.14258G>A in MT-ND6 has been identified as a unique feature in certain LHON families .

  Functional studies of cybrid cell lines carrying these combinations of variants demonstrated:

  • Normal cell viability compared to controls

  • Non-significant reduction in Complex I redox activity

  • Significantly reduced basal and FCCP-stimulated oxygen consumption rate (OCR)

  • Metabolic shift toward glycolysis (higher ECAR and lower OCR)

  • Significantly reduced ATP synthesis driven by Complex I substrates, but normal ATP synthesis with Complex II substrates

  These findings suggest that seemingly harmless polymorphic variants can collectively induce mild Complex I defects, potentially by affecting the E-channel of Complex I and altering proton pumping efficiency .

• How is MT-ND4L integrated into the assembly pathway of Complex I?

  The assembly of MT-ND4L into Complex I follows a sophisticated pathway. Complexome profiling studies reveal that Complex I assembly occurs through distinct modules:

  1. The Q-module and mitochondrial Complex I assembly (MCIA) complex first stabilize mtDNA-encoded ND2

  2. The ND2-module assembles and co-migrates with Q-module, ND1-module, and MCIA complex

  3. The ND4-module (which includes interactions with ND4L) assembles and joins this growing structure

  In cells with defects in assembly factors like RTN4IP1, although the ND4-module assembles and joins other modules, it tends to accumulate in sub-assemblies involving several ND4-module subunits (NDUFB5, NDUFB6, NDUFB10, and NDUFB11) and assembly factors TMEM70 and TMEM126A .

  Research indicates that certain assembly factors like AMC1 are specifically required for the production of mitochondrially-encoded Complex I subunits, particularly ND4, which has functional interactions with ND4L .

• What are the methodological considerations for expressing and purifying functional recombinant MT-ND4L?

  Expressing and purifying functional MT-ND4L presents several challenges due to its hydrophobic nature and normal embedding within the mitochondrial membrane. Based on current protocols for similar proteins:

  1. Expression Systems:

     • E. coli appears to be the predominant expression system for recombinant MT-ND4L proteins

     • Yeast expression systems are also utilized for some mitochondrial proteins

  2. Protein Tagging:

     • His-tagging is commonly employed for purification purposes

     • Tags are typically added to the N-terminus of the protein

  3. Storage and Stability:

     • Lyophilized powder forms typically have a shelf life of 12 months at -20°C/-80°C

     • Liquid forms have shorter shelf lives of approximately 6 months

     • Addition of glycerol (5-50%, with 50% being standard) is recommended for long-term storage

     • Repeated freeze-thaw cycles should be avoided

  4. Reconstitution:

     • Brief centrifugation before opening is recommended

     • Reconstitution in deionized sterile water to 0.1-1.0 mg/mL concentration

     • Working aliquots can be stored at 4°C for up to one week

• What methodologies can assess the functional integrity of recombinant MT-ND4L?

  Several techniques can evaluate whether recombinant MT-ND4L maintains its structural and functional properties:

  1. Complex I Activity Assays:

     • NADH oxidation rate measurement using spectrophotometric methods

     • Ubiquinone reduction assays

  2. Oxygen Consumption Analysis:

     • Measurement of basal and FCCP-stimulated oxygen consumption rates

     • Comparing OCR/ECAR ratios to detect metabolic shifts

  3. ATP Synthesis Measurements:

     • Using Complex I substrates (malate and glutamate)

     • Normalizing to citrate synthase activity

  4. Structural Analysis:

     • Blue-native gel electrophoresis to assess incorporation into Complex I

     • Complexome profiling to determine association with other subunits

  5. Membrane Integration Assays:

     • Alkaline extraction to determine membrane association

     • Protease protection assays to evaluate topology

• How can researcher study the role of MT-ND4L in the proton-pumping mechanism of Complex I?

  Investigating MT-ND4L's role in proton pumping requires specialized approaches:

  1. Site-Directed Mutagenesis:

     • Target conserved residues, particularly those near the putative E-channel of Complex I

     • The m.10680G>A variant (changing amino acid position 71) provides a natural model

  2. Proton Translocation Assays:

     • Using pH-sensitive dyes in reconstituted systems

     • Measuring proton gradients across membranes

  3. Structural Biology Approaches:

     • Electron microscopy to visualize structural changes

     • X-ray crystallography of Complex I with focus on MT-ND4L positioning

  4. Computational Modeling:

     • Molecular dynamics simulations of proton movement

     • Modeling effects of known mutations on channel structure

  5. Comparative Studies:

     • Analysis of proton pumping efficiency in cells with MT-ND4L variants

     • Comparison of OCR and membrane potential in control vs. mutant cells

• What is the current evidence linking MT-ND4L variations to neurodegenerative diseases?

  Research has established connections between MT-ND4L variations and neurodegenerative conditions:

  1. Leber Hereditary Optic Neuropathy (LHON):

     • T10663C (Val65Ala) mutation identified in several LHON families

     • m.10680G>A variant reported as pathogenic in three LHON families

     • Can occur alone or in combination with other mitochondrial mutations

  2. Alzheimer's Disease (AD):

     • A study involving 10,831 participants identified significant association of AD with:

       • A rare MT-ND4L variant rs28709356 C>T (minor allele frequency = 0.002; P = 7.3 × 10⁻⁵)

       • Gene-based test of MT-ND4L (P = 6.71 × 10⁻⁵)

     • These findings provide evidence for mitochondrial dysfunction in AD pathogenesis

  The mechanisms linking these variations to neurodegenerative phenotypes likely involve:

  • Compromised energy production in neuronal cells

  • Potential alterations in reactive oxygen species generation

  • Disrupted cellular homeostasis in high-energy demanding tissues like the optic nerve

• What experimental systems are most appropriate for studying MT-ND4L mutations?

  Several experimental systems offer advantages for studying MT-ND4L:

  Experimental System	Advantages	Limitations
  Cybrids	Allows study of mtDNA variants on controlled nuclear background	May not recapitulate tissue-specific effects
  Patient-derived fibroblasts	Represents natural disease state with patient's genetic background	Limited relevance to neuronal phenotypes
  DdCBE gene editing	Precise introduction of mtDNA mutations in model organisms	Technically challenging, potential off-target effects
  Recombinant protein systems	Controlled study of specific protein properties	Lacks cellular context
  Complexome profiling	Detailed analysis of protein complex assembly	Limited functional information

  The MitoKO library approach using DdCBE pairs (DddA-derived cytosine base editors) has been used to knock out every protein-coding gene of mouse mtDNA, including MT-Nd4l, by introducing premature stop codons . For MT-Nd4l specifically, researchers changed a coding sequence for Val90 and Gln91 (GTC CAA) to generate a premature stop codon (GTT-) .